| 麻黄的活性成分与临床应用进展 |
| |
| 引用本文： | 任海波,王迎春,麻景梅,李军山,牛丽颖.麻黄的活性成分与临床应用进展[J].中国药物警戒,2021(4):396-399. |
| |
| 作者姓名： | 任海波 王迎春 麻景梅 李军山 牛丽颖 |
| |
| 作者单位： | 河北中医学院;河北省中药配方颗粒技术创新中心;河北省中药材品质评价与标准化工程研究中心;神威药业集团有限公司 |
| |
| 基金项目： | 河北省自然科学基金资助项目(H2019423050);河北省中医药管理局科研计划项目(2016009)。 |
| |
| 摘 要： | 麻黄始载于《神农本草经》,化学成分复杂,具有发汗平喘、利尿、降血脂、抗氧化等多种药理活性,临床应用广泛。本文对麻黄的活性成分、药理作用、临床应用及应用禁忌等方面进行了综述,以期为麻黄及其相关制剂的进一步深入研究和临床用药安全提供参考。
|
| 关 键 词： | 麻黄 活性成分 不良反应 应用 禁忌 |
Active Ingredients of Ephedra and Their Clinical Application and Contraindications |
| |
| REN Haibo,WANG Yingchun,MA Jingei,LI Junshan,NIU Liying.Active Ingredients of Ephedra and Their Clinical Application and Contraindications[J].Chinese JOurnal of Pharmacovigilance,2021(4):396-399. |
| |
| Authors: | REN Haibo WANG Yingchun MA Jingei LI Junshan NIU Liying |
| |
| Institution: | (Hebei University of Chinese Medicine,Shijiazhuang,Hebei 050091,China;Hebei TCM Formula Granule Technology Innovation Center,Shijiazhuang,Hebei 050091,China;Hebei TCM Quality Evaluation and Standardization Engineering Research Center,Shijiazhuang,Hebei 050091,China;Shineway Pharmaceutical Group Company Limited,Shijiazhuang,Hebei 051430,China) |
| |
| Abstract: | Ephedra was first documented in"Shen Nong's Materia Medica".It has complex chemical components and has many pharmacological activities such as diaphoresis,relieving asthma,diuresis,lowering blood lipids and antioxidation.It has a wide range of clinical applications.This article reviews the active ingredients,pharmacological effects,clinical application and contraindications of Ephedra with a view to providing reference for further in-depth research and safety of clinical medication of Ephedra and its related preparations. |
| |
| Keywords: | Ephedra active ingredient adverse reaction application contraindication |
| 本文献已被 维普 等数据库收录！ |
|
